Continually Advancing Hemodialysis
Drawing on a 50-year heritage of transformative innovation in hemodialysis (HD),1 Vantive is continuing to advance HD in groundbreaking and meaningful ways.
88%
>111,000
800
The latest clinical insights
Explore our clinical data page to access studies and reports across various therapy areas.
Important Safety Information
Indications for Use: THERANOVA dialyzers are indicated for treatment of chronic and acute renal failure by Hemodialysis
Caution: Do not use THERANOVA dialyzers for HDF (hemodiafiltration) or HF (hemofiltration) due to higher permeability of larger molecular weight proteins such as albumin.
For safe and proper use of the device, please refer to the Instructions for Use.
Vantive, HDx and MCO are trademarks of Vantive Health LLC or its affiliates.
References
-
Vantive Health LLC. Data on file.
-
Vantive Health LLC. Symphony Market Model. 2023. Data on file
-
Vantive Health LLC. Global Services. Data on file.
-
Boschetti-de-Fierro A, Voigt M, Storr M, Krause B. MCO membranes: enhanced selectivity in high-flux class. Sci Rep. 2015;5:18448.